Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-011074

President sold 80,000 shares at $33.00 ($2,640,000)

  • President acquired 80,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RUBINSTEIN JULIE President 2020-02-19 Option exercise +25,000 $0.84 $21,000 25,000 D
RUBINSTEIN JULIE President 2020-02-19 Option exercise +55,000 $0.84 $46,200 80,000 D
RUBINSTEIN JULIE President 2020-02-19 Sale −80,000 $33.00 $2,640,000 0 D
Derivatives
RUBINSTEIN JULIE President 2020-02-19 Option exercise · Stock Option (Right to Buy) −25,000 0 D
RUBINSTEIN JULIE President 2020-02-19 Option exercise · Stock Option (Right to Buy) −55,000 305,000 D
Open-market sales · 80,000 sh · avg $33.00 · $2,640,000
Loading xslF345X03/doc4.xml…